Smokers reported that consuming milk, water, fruits and vegetables worsened the taste of cigarettes, while consuming alcohol, coffee and meat enhanced their taste, according to the scientists.
Kamal Motiram Vidhani, a resident of suburban Khar, slapped a legal notice on Wockhardt last month after he failed to receive suitable compensation from the pharmaceutical firm.
The U.S. Food and Drug Administration (FDA) announced the approval of HepaGam B for the prevention of hepatitis B reinfection in certain liver transplant patients. HepaGam B is the first product of its kind (an immune globulin product) approved for this purpose.
The Heart and Stroke Foundation (HSF) joined Toronto Public Health to release two new reports and urge the federal government to eliminate deadly processed trans fats in our food supply.
William Marler, a food safety advocate and attorney whose Seattle law firm, Marler Clark, has been contacted by three victims of an E. coli outbreak traced to a Lake Forest, California, Souplantation restaurant, called on Souplantation to pay the medical bills of all individuals who became ill with E. coli infections as part of the outbreak.
Australian health authorities have removed a medicine Zelmac for irritable bowel syndrome (IBS) from sale because of safety concerns.
A new drug for HIV has produced highly promising results in clinical trials, when combined with an existing treatment, researchers revealed.
The Food and Drug Administration (FDA) is urgently reminding the public that contact with baby turtles can pose a serious health risk to infants, small children, and adults with impaired immune systems as they can be natural hosts to Salmonella, a group of bacteria that can cause severe illness and death.
The U.S. Food and Drug Administration (FDA) announced the approval of HepaGam B for the prevention of hepatitis B reinfection in certain liver transplant patients.
As part of the Food and Drug Administration’s (FDA) on-going initiative to ensure that all marketed U.S. drugs have required marketing approval, the agency announced that companies must stop manufacturing and distributing unapproved suppository drug products containing trimethobenzamide hydrochloride.